This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endometroid carcinoma of ovary
C3_OVARY_ENDOMETROID
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
314 |
4. Check minimum number of eventsNone |
314 |
5. Include endpointsNone |
314 |
6. Filter based on genotype QC (FinnGen only) |
314 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Endometroid carcinoma of ovary
based on the number of shared cases.
Similar with more cases:
- Endometroid carcinoma of ovary, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)
- malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 314 | 314 | - |
| Unadjusted period prevalence (%) | 0.11 | 0.11 | - |
| Median age at first event (years) | 58.92 | 58.92 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 284
- Matched controls
- 2840
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
+∞
323.0
246
*
8380/3-C56.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of ovary
+∞
217.7
180
*
128
Kela drug reimbursment
Cancers of female genital organs
80.7
133.7
147
37
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
203.0
121.4
119
10
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
87.4
79.1
86
14
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
33.2
76.6
102
47
JAL30
NOMESCO Finland
Omentectomy
61.0
72.0
83
19
C56
ICD-10 Finland
Malignant neoplasm of ovary
151.1
67.3
69
6
H02AB02
ATC
dexamethasone; systemic
12.7
66.1
135
189
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
127.2
65.2
68
7
A03FA01
ATC
metoclopramide; systemic, rectal
9.5
65.1
183
454
JEA00
NOMESCO Finland
Appendectomy
18.4
60.2
98
79
A04AA01
ATC
ondansetron; systemic, rectal
13.6
56.7
107
121
WX302
NOMESCO Finland
Thoracal epidural anesthesy
17.1
51.9
86
70
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
20.8
49.3
75
48
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
11.5
44.3
89
108
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
12.6
41.2
78
83
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
14.5
37.2
65
57
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
13.0
36.4
67
66
B01AB10
ATC
tinzaparin; parenteral
8.9
35.4
82
124
JN4BD
NOMESCO Finland
Extensive body CT
7.0
32.4
90
177
A04AA03
ATC
tropisetron; systemic
89.9
29.4
32
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
27.2
27.8
38
16
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
57.7
26.8
31
6
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
27.3
26.4
36
15
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
64.3
25.5
29
5
1830A
ICD-9 Finland
Malignant neoplasm of ovary and other uterine adnexa, Ovary
136.5
24.0
25
*
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
249.3
23.0
23
*
TPH07
NOMESCO Finland
Cathetrisation of artery
5.2
21.2
73
178
LCD00
NOMESCO Finland
Hysterectomy
6.5
20.7
57
106
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
3.3
20.4
149
704
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
9.6
19.8
41
49
JAL00
NOMESCO Finland
Biopsy of peritoneum
34.1
19.6
25
8
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
4.1
18.9
84
262
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
9.2
18.5
39
48
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
35.6
18.3
23
7
C56.72
ICD-10 Finland
Mucinous epithelial carcinoma of the ovary
+∞
17.9
17
*
B01AB05
ATC
enoxaparin; parenteral
3.1
17.7
145
720
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
8.0
17.3
40
57
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
33.9
17.3
22
7
JAH00
NOMESCO Finland
Laparotomy
10.5
16.9
33
35
L03AA13
ATC
pegfilgrastim; parenteral
7.0
16.6
42
69
L03AA14
ATC
lipegfilgrastim; parenteral
12.3
16.2
29
26
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
4.1
15.7
66
193
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
17.7
15.0
23
14
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
8.9
15.0
32
40
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.1
14.9
64
190
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
36.0
13.7
17
5
JN4AD
NOMESCO Finland
Body CT examination
4.7
13.7
48
117
C567
ICD-10 Finland
NA
+∞
13.6
13
*
JAL31
NOMESCO Finland
Laparoscopic omentectomy
27.3
13.5
18
7
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.7
13.4
126
647
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
73.2
12.7
14
*
L03AA02
ATC
filgrastim; parenteral
7.8
12.7
29
41
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
21.2
12.6
18
9
R18
ICD-10 Finland
Ascites
10.4
12.5
24
25
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
19.1
12.2
18
10
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
9.6
12.0
24
27
WX402
NOMESCO Finland
General anaesthesia
3.1
11.9
73
283
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
24.1
11.7
16
7
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
13.5
11.3
19
15
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
12.6
11.0
19
16
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
5.8
11.0
31
59
Z51.5
ICD-10 Finland
Palliative care
4.8
10.6
35
80
C56.74
ICD-10 Finland
Mesonephroid epithelial carcinoma of the ovary
+∞
10.5
10
*
D39.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified
24.4
10.3
14
6
JFB46
NOMESCO Finland
Resection of sigmoid colon
24.4
10.3
14
6
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
6.9
10.3
25
39
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
15.3
10.1
16
11
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
20.9
9.9
14
7
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
3.0
9.8
62
243
A04AA02
ATC
granisetron; systemic, transdermal
4.1
9.8
38
102
D70.82
ICD-10 Finland
Drug-induced neutropenia
14.0
9.8
16
12
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
57.0
9.7
11
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.5
9.3
33
81
N80.1
ICD-10 Finland
Endometriosis of ovary
6.9
9.2
22
34
JAH01
NOMESCO Finland
Laparoscopy
4.7
9.1
30
69
ZXC40
NOMESCO Finland
Use of ultrasound
12.1
8.7
15
13
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
5.6
8.5
24
46
ZX120
NOMESCO Finland
Intravenous
3.2
8.4
44
152
8440/3-C56.9
ICD-O-3
Cystadenocarcinoma, NOS, of ovary
+∞
8.4
8
*
D39.19
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary with unspecified histology
9.3
8.2
16
18
X77
ICPC
Malignant neopl genital female other
17.8
8.1
12
7
8441/3-C56.9
ICD-O-3
Serous carcinoma, NOS, of ovary
22.8
8.1
11
5
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
13.6
8.0
13
10
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
15.6
7.8
12
8
L01CB01
ATC
etoposide; systemic
46.3
7.8
9
*
Z31.5
ICD-10 Finland
Genetic counselling
4.1
7.6
29
77
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
10.4
7.6
14
14
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
7.5
7.6
17
24
WW500
NOMESCO Finland
Blood transfusion
5.3
7.6
22
44
WF049
NOMESCO Finland
Radiotherapy of metastasis
5.9
7.5
20
36
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
8.7
7.4
15
18
8205
FHL
Subradical ovarian malignancy removal (includes possible genital and omet removal)
+∞
7.3
7
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
5.9
7.2
19
34
A04AA55
ATC
palonosetron, combinations; systemic
5.2
7.1
21
43
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
9.1
7.1
14
16
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
9.1
7.1
14
16
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
6.6
7.1
17
27
N02AA05
ATC
oxycodone; systemic
2.5
7.0
58
265
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
6.9
78
413
K56.7
ICD-10 Finland
Ileus, unspecified
8.6
6.9
14
17
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
17.2
6.8
10
6
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
41.1
6.8
8
*
JAW96
NOMESCO Finland
Other operation on abdominal wall, peritoneum, mesentery or omentum
41.1
6.8
8
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
41.1
6.8
8
*
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
7.1
6.6
15
22
18301
ICD-8 Finland
Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary
71.4
6.5
7
*
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
14.7
6.4
10
7
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
6.8
6.4
15
23
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
3.7
6.2
26
76
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
201
229
22.61
183.39
12.2
3.1
44.4
72.9
u/ml
0.61
195
220
116
319
5.18
41.10
3.3
3.7
4.1
7.9
ug/l
1.09
91
264
89
290
3.89
23.86
9.3
5.6
0.9
1.5
mmol/l
0.74
75
240
200
1226
2.74
16.35
5.2
3.8
34.0
35.5
g/l
2.93
193
1126
130
646
2.73
16.20
2.3
2.0
—
—
—
0
0
200
1263
2.61
14.78
4.2
3.8
—
—
—
0
0
48
146
3.70
13.79
13.4
6.7
95.6
94.6
%
1.86
48
146
47
149
3.53
12.66
13.7
6.5
0.8
0.7
%
0.33
47
149
47
151
3.48
12.40
13.3
6.5
1.4
1.3
%
0.24
47
151
17
27
6.60
10.38
1.0
1.2
—
—
—
0
0
210
1485
2.25
10.27
9.4
5.3
10.2
10.1
umol/l
0.03
201
1386
30
85
3.80
9.48
6.8
3.8
3.7
3.8
mmol/l
0.35
30
78
35
111
3.42
9.37
3.0
2.8
36.5
1414.6
u/ml
0.60
27
98
215
1579
2.15
8.95
17.4
8.6
3.5
4.0
e9/l
3.26
186
1393
16
28
5.97
8.89
1.0
1.8
3.6
140.1
u/ml
0.51
16
28
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
64
3.98
8.24
4.0
2.3
0.4
0.4
u/ml
—
10
40
31
99
3.36
8.20
6.6
3.8
1.3
1.3
mmol/l
0.09
31
99
183
1379
1.78
5.83
4.9
4.2
0.0
0.0
estimate
0.50
24
241
41
184
2.41
5.82
5.4
4.0
7.4
8.9
mmol/l
1.01
41
169
181
1367
1.77
5.66
7.1
5.5
0.0
0.0
estimate
0.00
23
240
176
1336
1.72
5.25
7.6
4.8
1.2
1.2
mmol/l
8.13
169
1197
233
2633
0.55
4.69
4.4
4.6
4.9
4.8
mmol/l
0.30
213
2403
94
616
1.75
4.65
1.9
1.6
1.6
1.0
mg/l
1.81
79
476
228
2588
0.57
4.56
5.0
5.4
1.8
2.4
mu/l
0.62
208
2343
242
2698
0.55
4.42
4.9
5.2
2.8
2.8
mmol/l
0.19
219
2447
248
2125
1.79
4.30
10.3
6.9
81.6
77.7
u/l
1.04
233
1960
50
277
1.96
4.19
2.4
2.3
4.2
7.1
umol/l
2.43
44
239
182
1444
1.62
4.19
7.9
5.6
1.2
1.2
mmol/l
8.46
169
1216
233
2616
0.58
4.14
4.2
4.5
1.6
1.6
mmol/l
0.47
209
2377
222
2519
0.59
4.02
5.6
6.0
39.9
39.8
mmol/mol
0.02
198
2311
237
2645
0.58
4.02
4.6
4.8
5.9
5.9
mmol/l
0.11
215
2386
37
192
2.05
3.72
1.4
1.5
—
—
—
0
0
44
245
1.93
3.64
3.4
2.6
2.8
2.6
mmol/l
0.12
34
200
125
933
1.56
3.56
3.5
3.1
—
—
—
0
0
195
2255
0.64
3.41
4.2
4.4
14.8
15.0
pmol/l
0.36
173
2037
25
117
2.24
3.26
2.3
2.6
25.1
24.8
mmol/l
0.11
19
106
66
432
1.67
3.18
2.6
2.8
1.7
1.3
e6/l
0.40
32
229
188
1570
1.49
2.98
7.2
4.1
6.8
6.6
mmol/l
0.53
181
1454
18
368
0.46
2.74
3.8
4.6
28.0
33.8
%
—
9
230
97
725
1.49
2.61
2.9
3.1
0.4
0.5
e6/l
0.61
69
535
81
589
1.51
2.47
1.3
1.4
—
—
—
0
0
101
1267
0.70
2.25
2.4
2.3
82.9
79.9
nmol/l
0.41
90
1106
26
144
1.88
2.22
1.7
1.4
—
—
—
0
0
9
30
3.06
2.16
1.3
1.5
—
—
—
0
0
56
388
1.54
2.13
2.6
3.1
3.3
4.1
e6/l
0.32
24
187
42
620
0.63
2.11
1.2
1.2
0.6
1.7
u/ml
—
8
160
230
2506
0.69
2.11
3.8
4.1
1.3
1.3
mmol/l
0.62
202
2253
108
857
1.40
2.04
2.8
2.2
57.8
56.6
u/l
0.07
99
774
8
26
3.13
2.02
1.4
1.6
—
—
—
0
0
160
1356
1.37
2.01
5.2
4.1
0.0
0.0
estimate
0.00
25
248
7
21
3.38
1.97
1.3
2.0
—
—
—
0
0
40
265
1.58
1.85
1.7
2.2
27.1
32.6
u/l
0.61
32
218
9
36
2.54
1.75
1.3
1.5
—
—
—
0
0
66
860
0.71
1.74
2.0
2.0
99.8
131.1
u/l
1.02
58
810
5
13
3.89
1.72
1.4
1.5
—
—
—
0
0
5
13
3.89
1.72
1.4
1.5
—
—
—
0
0
24
144
1.72
1.63
4.0
2.0
1.3
1.1
%
0.58
24
144
5
14
3.61
1.62
1.4
1.4
—
—
—
0
0
187
2073
0.76
1.59
4.1
4.4
16.5
13.0
mm/h
1.94
167
1883
15
78
1.97
1.57
2.9
2.5
—
—
—
0
0
15
78
1.97
1.57
1.5
1.5
—
—
—
0
0
123
1048
1.29
1.35
5.0
3.2
2.4
2.4
mmol/l
0.35
112
898
37
511
0.69
1.34
1.3
1.3
45.3
12.2
u/ml
0.49
11
186
0
40
0.00
1.33
0.0
1.1
—
—
—
0
0
8
37
2.19
1.22
1.0
1.4
—
—
—
0
0
6
26
2.33
1.19
1.3
1.5
—
—
—
0
0
26
175
1.53
1.17
4.2
2.6
4.4
4.5
pmol/l
0.08
26
148
11
58
1.93
1.13
1.5
1.6
—
—
—
0
0
10
52
1.95
1.07
1.0
1.3
—
—
—
0
0
134
1502
0.81
1.04
2.5
2.7
—
—
—
0
0
40
304
1.36
0.98
1.7
1.8
—
—
—
0
0
6
28
2.16
0.92
1.5
1.2
—
—
—
0
0
17
252
0.66
0.90
3.1
2.7
85.3
74.6
ng/l
0.37
17
222
104
1183
0.82
0.90
3.1
2.6
114.2
94.6
ug/l
0.51
96
1074
31
410
0.73
0.89
1.4
1.4
—
—
—
0
0
44
347
1.31
0.86
2.9
2.2
23.1
20.5
%
0.52
39
293
63
522
1.26
0.85
4.6
3.8
23.0
150.3
ng/l
2.27
50
415
39
303
1.33
0.85
1.8
1.7
—
—
—
0
0
65
770
0.80
0.82
1.8
1.6
1.6
1.3
mmol/l
1.20
55
648
0
26
0.00
0.79
0.0
1.3
—
—
—
0
0
0
26
0.00
0.79
0.0
1.3
—
—
—
0
0
0
26
0.00
0.79
0.0
1.3
—
—
—
0
0
108
1210
0.84
0.77
2.2
2.0
82.0
100.0
pmol/l
2.82
50
542
10
60
1.69
0.73
1.3
1.4
—
—
—
0
0
116
1040
1.18
0.72
4.5
3.7
29.7
62.0
ng/l
0.48
87
740
9
58
1.57
0.70
1.0
1.2
—
—
—
0
0
9
58
1.57
0.70
1.0
1.2
—
—
—
0
0
275
2827
0.78
0.69
17.6
10.5
23.6
23.1
u/l
0.24
269
2701
52
433
1.24
0.68
1.7
1.7
—
—
—
0
0
5
28
1.80
0.66
1.0
1.1
—
—
—
0
0
30
235
1.31
0.64
2.7
2.8
50.8
61.5
ml/min/173m2
1.15
17
94
9
141
0.63
0.61
1.0
1.6
—
—
—
0
0
0
21
0.00
0.60
0.0
1.7
—
23.8
—
0
6
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
8
52
1.55
0.60
1.3
1.5
—
—
—
0
0
0
23
0.00
0.58
0.0
1.1
—
94.4
—
0
5
6
35
1.73
0.58
1.2
1.5
—
—
—
0
0
5
86
0.57
0.57
1.0
1.6
—
—
—
0
0
45
531
0.82
0.56
1.2
1.3
18.4
39.3
iu/ml
—
10
176
6
38
1.59
0.54
1.3
1.1
—
—
—
0
0
49
569
0.84
0.52
1.4
1.7
1328.7
1220.3
nmol/l
0.31
37
410
44
377
1.19
0.46
12.7
6.5
—
—
—
0
0
274
2800
0.83
0.46
29.9
16.5
71.2
70.9
umol/l
0.11
274
2800
5
85
0.58
0.46
1.2
1.2
—
2.7
—
0
6
113
1043
1.13
0.45
5.2
4.4
—
—
—
0
0
7
50
1.41
0.45
1.0
1.1
—
—
—
0
0
7
51
1.38
0.44
1.4
1.6
—
—
—
0
0
0
15
0.00
0.41
0.0
2.0
—
—
—
0
0
0
15
0.00
0.41
0.0
2.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
272
2658
1.17
0.40
20.3
13.7
34.4
21.4
mg/l
6.79
245
2083
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
6
42
1.44
0.35
1.5
1.3
—
—
—
0
0
6
87
0.68
0.33
4.3
4.4
—
2.7
—
0
10
6
87
0.68
0.33
1.3
2.3
0.0
0.0
g/l
—
6
80
6
88
0.68
0.33
1.0
1.2
—
—
—
0
0
16
197
0.80
0.32
1.3
1.2
140.3
183.7
iu/ml
—
9
86
13
102
1.29
0.30
1.5
1.4
—
—
—
0
0
7
55
1.28
0.30
1.3
1.5
—
—
—
0
0
25
214
1.18
0.29
4.7
3.1
112.3
212.5
ng/l
1.02
20
201
229
2346
0.91
0.27
28.3
15.2
36.3
38.9
%
4.71
162
1569
65
702
0.91
0.26
1.7
1.5
24.4
22.3
nmol/l
0.52
57
578
5
71
0.70
0.26
1.4
1.8
—
—
—
0
0
61
657
0.91
0.23
1.9
2.5
8858.7
9552.5
umol/l
0.03
52
552
5
39
1.29
0.23
1.2
1.6
—
—
—
0
0
18
153
1.19
0.23
1.3
1.5
—
—
—
0
0
79
744
1.08
0.22
5.1
4.6
0.0
0.0
estimate
0.48
23
246
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
27.0
—
0
10
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
161
1662
0.94
0.21
3.8
2.9
52.7
44.0
u/l
0.81
145
1516
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
91
864
1.07
0.20
3.3
2.8
1843.4
1219.1
ng/l
0.38
81
725
0
14
0.00
0.20
0.0
1.9
—
51.6
—
0
9
29
262
1.12
0.18
2.5
3.5
—
—
—
0
0
7
62
1.13
0.17
1.0
1.3
—
—
—
0
0
5
67
0.74
0.17
1.2
1.2
—
33.4
—
0
9
7
87
0.80
0.14
1.0
1.3
—
—
—
0
0
72
687
1.06
0.14
2.2
2.2
3.4
3.3
mg/l
0.06
59
572
9
110
0.81
0.13
1.0
1.3
—
—
—
0
0
57
594
0.95
0.10
1.5
1.8
1266.1
12931506.6
pmol/l
0.50
41
464
15
135
1.12
0.10
2.8
3.6
5.3
5.2
kpa
0.06
15
126
5
46
1.09
0.09
1.0
1.3
—
—
—
0
0
10
114
0.87
0.09
1.3
2.1
—
—
—
0
0
5
61
0.82
0.08
3.2
2.7
27.8
25.5
mmol/l
—
5
51
7
65
1.08
0.08
1.0
1.1
—
12.1
—
0
7
8
74
1.08
0.07
1.4
1.4
—
—
—
0
0
16
172
0.93
0.06
2.4
1.7
—
—
—
0
0
276
2773
0.96
0.05
27.6
16.1
3.9
3.9
mmol/l
0.45
270
2683
252
2506
1.03
0.04
21.2
13.2
76.1
76.8
ml/min/173m2
0.22
220
2031
276
2769
0.97
0.02
28.1
16.0
139.3
139.7
mmol/l
1.88
270
2685
10
94
1.07
0.01
1.5
1.6
—
—
—
0
0
14
143
0.98
0.00
1.1
1.3
—
—
—
0
0
10
104
0.96
0.00
1.5
1.6
—
—
—
0
0
15
154
0.97
0.00
1.1
1.7
—
—
—
0
0
60
595
1.01
0.00
3.0
2.8
2.5
2.5
mmol/l
0.36
54
518
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
9
0.00
0.00
0.0
1.0
—
132.8
—
0
9
5
49
1.02
0.00
1.0
1.1
0.7
0.6
nmol/l
—
5
44
0
9
0.00
0.00
0.0
1.0
—
9.3
—
0
9
0
8
0.00
0.00
0.0
2.9
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
8.7
—
0
5
9
95
0.95
0.00
1.1
1.1
—
—
—
0
0
13
130
1.00
0.00
1.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
1.9
—
0
5
0
6
0.00
0.00
0.0
1.0
—
96.8
—
0
6
0
5
0.00
0.00
0.0
1.0
—
15.6
—
0
5
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
9
94
0.96
0.00
1.1
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
11.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
8
79
1.01
0.00
1.1
1.6
—
112.0
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_OVARY_ENDOMETROID – Endometroid carcinoma of ovary
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).